Product Description

Cytochrome P450 2A6/7/13 Polyclonal Antibody

Sizes: 50μl, 100μl

Catalogue Numbers: BZ16185-50, BZ16185-100

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Background: Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1, 4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.

Category: Primary Antibody

Reactivity: Human

Host: Rabbit

Applications: WB, ELISA

Alternate Names: CYP2A6, CYP2A3, Cytochrome P450 2A6, 1, 4-cineole 2-exo-monooxygenase, CYPIIA6, Coumarin 7-hydroxylase, Cytochrome P450 IIA3, Cytochrome P450(I), CYP2A7, Cytochrome P450 2A7, CYPIIA7, Cytochrome P450 IIA4, CYP2A13, Cytochrome P450 2A13, CYPIIA13

Clonality: Polyclonal

Conjugate: Unconjugated

Modification: Unmodified

Immunogen: Synthesized peptide derived from the Internal region of human CYP2A6/7/13.

Dilution: WB: 1/500-1/1000 ELISA: 1/10000

Purification: Affinity Purified

Specificity: IgG

Molecular Weight: Calcμlated MW: 56 kDa, Observed MW: 56 kDa

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

SwissProt: P11509/P20853/Q16696

Product: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

Research Use Only